LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml

7680678260017 CH-67826 H05AA02 07.99.0.

Reimbursement limitations:

FORSTEO 2

Pour un traitement en deuxième ligne de femmes post-ménopausées ou d'hommes qui développent de nouvelles …

LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml
LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml
LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml
1 / 3
google

Details

Product number
6782601
CPT
-
Packaging group
1
Unit
Injektor(en), vorgefüllt/Pen
Composition
teriparatidum ADNr 250 µg, acidum aceticum glaciale, natrii acetas trihydricus mannitolum, metacresolum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml, corresp. teriparatidum ADNr 20 µg, natrium 1.4 µg pro 80 µl.

Articles (1)

Livogiva 20 mcg/80 mcl, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
20.0 UG Substance WIZUS
(N/A)
1.4 UG Substance HBESI

Reimbursement information

Public price
CHF 278.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2021

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
67826
Drug name
Livogiva, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
H05AA02
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
17/02/2021
Authorization expiration date
15/07/2025
IT number
07.99.0.
Domain
Human medicine
Field of application
Postmenopausale Osteoporose bei Frauen; primäre und hypogonadale Osteoporose bei Männern; Glukokortikoid-induzierte Osteoporose bei Erwachsenen mit erhöhtem Frakturrisiko.

Packaging details

Description (FR)
LIVOGIVA sol inj 20 mcg/80mcl stylo pré 2.7 ml
Description (DE)
LIVOGIVA Inj Lös 20 mcg/80mcl Fertpen 2.7 ml
Market launch
17/02/2021
Market withdrawal
16/07/2025
Narcotic (BTM)
No

Available generics

Teriparatid-Mepha, Injektionslösung im Fertigpen
CHF 225.60
View